Personal and family history Prescribing information for this medication class warns against use in patients with a personal or family history of medullary thyroid carcinoma, a rare form of thyroid cancer, or the genetic condition multiple endocrine neoplasia syndrome type 2
receives research funding by Novo Nordisk and has received speaking fees from Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Merck, AstraZeneca and Mercodia
Talk to your doctor first if you need or want to stop taking GLP-1
The medication is generally used in higher doses to promote weight loss
The slower speed, which causes the stomach to empty more gradually, and generally eating less food can possibly give less beneficial gas-causing bacteria too much time to grow, adds nutritionist and author of The Small Change Diet , Keri Gans, RDN